As the cost of an individual genome becomes more attainable, laboratories in North America and Europe are experimenting with offering…

Genome and exome sequencing is transforming cancer diagnostics and care. In the first installment of our Advancing Clinical NGS series,…

With recent announcements of software retirements in the clinical NGS industry, many clinical diagnostic labs are looking for new variant…

In its latest release, QCI Interpret advances market-leading NGS interpretation software with artificial intelligence-driven insights to enable clinical exome completeness…

Interpretation of genomic variants in tumor samples still presents a challenge in clinical settings. Variant interpretation is fragmented across disparate…

QCI Interpret for Oncology will support the Danish National Genome Center’s new national initiative—one of Europe’s largest precision oncology projects…

There’s a better clinical genomics workspace for your 523-gene panel. Find out why now is the perfect time to switch…

How genomic databases and bioinformatic tools from QIAGEN Digital Insights are ending the diagnostic odyssey of rare diseases one gene…

The QCI Interpret Winter 2023 Release brings new variant assessment tools, functionality improvements, and expanded bibliographic coverage for carrier screening…

Nearly two dozen new fully curated somatic genes and 387 clinical trials included in COSMIC Actionability v8 release We are…

In 2022, the world crossed a sobering new threshold. Over 20 million people were diagnosed with cancer, and 10 million…

A new balancing act: How do clinical cancer geneticists and genetic counselors manage more patients with less time? The COVID-19…